Wulffraat, Nico
,
Kamphuis, Sylvia
Swart, Joost F.
Vastert, Sebastiaan
Van Dijkhuizen, Pieter
van Pelt, Philomine
van Dijk-Hummelman, Annette
Consolaro, Alessandro
Bovis, Francesca
Ruperto, Nicolino
Article History
Received: 22 December 2017
Accepted: 11 January 2018
First Online: 7 April 2018
Compliance with ethical standards
:
: Dr. Swart, Dr. Kamphuis, Dr. van Dijkhuizen, Dr. Van Dijk-Hummelman, Dr. Wulffraat, Dr. Vastert and Dr. van Pelt report funding support from Istituto Giannina Gaslini, Genoa, Italy, for the translation and data collection performed at his site within the EPOCA project. Dr. Swart has also received a Grant from Pfizer, outside the submitted work. Dr. Wulffraat has also received Grants from Pfizer and AbbVie and personal fees from Novartis, outside the submitted work. Dr. Ruperto has received Grants from BMS, Hoffman-La Roche, Janssen, Novartis, Pfizer, Sobi, during the conduct of the study and personal fees and speaker honorarium from Abbvie, Ablynx, Amgen, AstraZeneca, Baxalta Biosimilars, Biogen Idec, Boehringer, Bristol Myers Squibb, Celgene, Eli-Lilly, EMD Serono, Gilead Sciences, Janssen, Medimmune, Novartis, Pfizer, Rpharm, Roche, Sanofi, Servier and Takeda. Dr. Consolaro and Dr. Bovis have nothing to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study as per the requirement of the local ethical committee.